Massimo Andreoni
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- COVID-19 Clinical Research Studies
Papers in
-
- HIV/AIDS drug development and treatment 78
- HIV/AIDS Research and Interventions 43
- COVID-19 Clinical Research Studies 22
- Epidemiology 96
- Cytomegalovirus and herpesvirus research 29
- Hepatitis B Virus Studies 27
- Co-authors
- Loredana Sarmati (144 shared papers)Emanuele Nicastri (39 shared papers)Stefano Vella (23 shared papers)Barbara Ensoli (17 shared papers)Giovanni Rezza (26 shared papers)Lucia Palmisano (13 shared papers)Carlo Federico Perno (46 shared papers)Sergio Bernardini (14 shared papers)
- Journals
- Journal of Medical Virology (19 papers)AIDS (12 papers)Journal of Clinical Microbiology (11 papers)PLoS ONE (10 papers)Clinical Microbiology and Infection (8 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Massimo Andreoni
305 papers receiving 5.5k citations
Peers
Comparison fields: 5 of 140
- Virology 1.2k
- Infectious Diseases 2.5k
- Hepatology 650
- Epidemiology 1.7k
- Oncology 882
Countries citing papers authored by Massimo Andreoni
This map shows the geographic impact of Massimo Andreoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Andreoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Andreoni more than expected).
Fields of papers citing papers by Massimo Andreoni
This network shows the impact of papers produced by Massimo Andreoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Andreoni. The network helps show where Massimo Andreoni may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Andreoni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 320 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 156 | |
| 2 | 1996 | 154 | |
| 3 | 2020 | 153 | |
| 4 | 1999 | 122 | |
| 5 | 2020 | 111 | |
| 6 | 1999 | 109 | |
| 7 | 2002 | 106 | |
| 8 | 2005 | 106 | |
| 9 | 2007 | 95 | |
| 10 | 2020 | 85 | |
| 11 | 2001 | 83 | |
| 12 | Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. | 2011 | 77 |
| 13 | 2013 | 74 | |
| 14 | 2012 | 72 | |
| 15 | 2002 | 65 | |
| 16 | 1996 | 64 | |
| 17 | 2014 | 63 | |
| 18 | 2021 | 62 | |
| 19 | 2020 | 61 | |
| 20 | 2021 | 61 |
About Massimo Andreoni
Massimo Andreoni is a scholar working on Infectious Diseases, Epidemiology, Virology, Hepatology and Oncology, having authored 320 papers that have together received 5.6k indexed citations. Recurring topics across this work include HIV Research and Treatment (82 papers), HIV/AIDS drug development and treatment (78 papers), Hepatitis C virus research (56 papers), HIV/AIDS Research and Interventions (43 papers), Viral-associated cancers and disorders (33 papers), Cytomegalovirus and herpesvirus research (29 papers), Hepatitis B Virus Studies (27 papers) and COVID-19 Clinical Research Studies (22 papers). The work is most often cited by research in Virology (1.2k citations), Infectious Diseases (2.5k citations), Hepatology (650 citations), Epidemiology (1.7k citations) and Oncology (882 citations). Massimo Andreoni has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Loredana Sarmati, Emanuele Nicastri, Stefano Vella, Barbara Ensoli, Giovanni Rezza, Lucia Palmisano, Carlo Federico Perno, Sergio Bernardini, Gabriella d’Ettorre and Saverio Giuseppe Parisi. Their work appears in journals such as Journal of Medical Virology, AIDS, Journal of Clinical Microbiology, PLoS ONE and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.